摘要
尿激酶起先被认识具有溶解血栓的作用。近年来人们发现它在肾脏疾病的治疗中具有独特功效，可降低蛋白尿，保护肾功能，能防治肾脏纤维化。本文就相关问题进行了概述。
出处
《国际泌尿系统杂志》
2007年第2期261-264,共4页
International Journal of Urology and Nephrology
参考文献23
-
1Beqaj S. Identification of cells responsible for urokinase - type plasminogen activator synthesis and secretion in human diploid kidney cell cultures. In Vitro Cell Dev Biol Anim,2004,40(3-4):102 - 107.
-
2Guoqiang Zhang et al. Urokinase Receptor Deficiency Accelerates Renal Fibrosis in Obstructive Nephropathy. J Am Soc Nephrol,2003,14:1254 - 1271.
-
3Loskutoff DJ, Quigley JP. PAI - 1, fibrosis, and the elusive provisional fibrin matrix. J Clin Invest,2000,106:1441 - 1443.
-
4Yukihiko Kawasaki, MD, Junzo Suzuki, et al. Efficacy of Methylprednisolone and Urokinase Pulse Therapy for Severe Henoch - Sch? nlein Nephritis. PEDIATRICS Vol. 111 No. 4 April 2003: pp. 785-789.
-
5Chunsheng Xi. Effects of alterations of glomerular fibrin deposition on renal inflammation in rats at different age stages. J Gerontol A Biol Sci Med Sci ,2005,60(9):1099 - 1110.
-
6Guoqiang Zhang. Mitogenic signaling of urokinase receptor - deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor - related protein. J Am Soc Nephrol,2004,15:2090-2102.
-
7Naldini L. Biological activation of pro - HGF ( hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J Biol Chem, 1995,270:603 - 611.
-
8Shirato K. Thrombin stimulates production of fibronectin by human proximal tubular epithelial cells via a transforming growth factor - |beta| - dependent mechanism. Nephrol Dial Transplant November 1,2003,18(11):2248-2254.
-
9Jin T. Urokinase- type plasminogen activator, an endogenous antibiotic. J Infect Dis,2005,192 (3):429-437.
-
10Gyetko MR. Urokinase is required for the pulmonary inflammatory response to cryptococcus neoformans. J Clin Invest, 1996,97: 1818-1826.
同被引文献4
-
1楼秋英.尿激酶联合甲泼尼龙治疗IgA肾病的护理[J].现代中西医结合杂志,2007,16(23):3402-3403. 被引量：5
-
2罗正茂,童俊容,张虹,朱起之,张建林.尿激酶治疗慢性肾功能不全的效果[J].实用医学杂志,2006,22(17):2050-2051. 被引量：8
-
3美国NKF-K/DCQI工作组.慢性肾脏病及透析的临床实践指南(附述评)[M].北京:人民卫生出版社,2003:6-7.
-
4郭秀芳.小剂量尿激酶治疗60例进展型脑梗死的护理[J].中国实用神经疾病杂志,2008,11(1):78-78. 被引量：1
-
1李大林,陈允惠,颜京强,张鲲,齐浩山.急性下肢深静脉血栓的介入治疗[J].临床普外科电子杂志,2013,1(1):44-46. 被引量：7
-
2郭仕峰,薛彦忠,项建平,田立强.介入溶栓治疗急性脑梗死23例[J].实用医学杂志,2005,21(6):637-638. 被引量：1
-
3郑达武.低分子肝素联合血栓通早期使用在防治脾切除术后门静脉血栓的应用[J].齐齐哈尔医学院学报,2013,34(11):1619-1620. 被引量：6
-
4盖景超.救命的纳豆酵素[J].医食参考,2009(10):48-48.
-
5符誉.下肢深静脉血栓形成治疗体会[J].岭南现代临床外科,1998(3):167-167. 被引量：1
-
6张嘉玲.酵素疗法的独特功效[J].养生大世界（A版）,2008(5):27-27.
-
7刘春来,刘锁民,刘屹立,王平.尿激酶治疗血液透析患者动静脉内瘘血栓形成的临床体会[J].疑难病杂志,2006,5(3):198-199. 被引量：8
-
8余国膺.应立即处理的六种严重症状[J].中国心脏起搏与心电生理杂志,2009,23(6):491-491.
-
9彭新静.中西医结合介入治疗股骨头缺血性坏死的护理[J].广西中医药,2002,25(4):51-51.
-
10赵景祥.星状神经节阻滞并发症浅析[J].中国医学创新,2009,6(19):160-161. 被引量：2
